These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7585208)

  • 1. HIV and CD26.
    Dalgleish A
    Nat Med; 1995 Sep; 1(9):881-2. PubMed ID: 7585208
    [No Abstract]   [Full Text] [Related]  

  • 2. The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression.
    Blanco J; Valenzuela A; Herrera C; Lluís C; Hovanessian AG; Franco R
    FEBS Lett; 2000 Jul; 477(1-2):123-8. PubMed ID: 10899322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line.
    Oravecz T; Roderiquez G; Koffi J; Wang J; Ditto M; Bou-Habib DC; Lusso P; Norcross MA
    Nat Med; 1995 Sep; 1(9):919-26. PubMed ID: 7585218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.
    Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
    Adv Exp Med Biol; 1997; 421():185-92. PubMed ID: 9330696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigators detail HIV's fatal handshake.
    Cohen J
    Science; 1996 Oct; 274(5287):502. PubMed ID: 8928003
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA-DR peptide inhibits HIV-induced syncytia.
    Lewis DE; Ulrich RG; Atassi H; Atassi MZ
    Immunol Lett; 1990 May; 24(2):127-31. PubMed ID: 2191918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VIP1-12 is a ligand for the CD4/human immunodeficiency virus receptor.
    Sacerdote P; Ruff MR; Pert CB
    Ann N Y Acad Sci; 1988; 527():574-8. PubMed ID: 2839089
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral effects of CD4 derivatives.
    Capon DJ; Ward RH
    Curr Opin Immunol; 1989-1990 Feb; 2(3):433-8. PubMed ID: 2576772
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular analysis of receptor binding and infectivity of the human immunodeficiency virus.
    Cordonnier A; Montagnier L
    Res Virol; 1989; 140(5):456-60. PubMed ID: 2555855
    [No Abstract]   [Full Text] [Related]  

  • 11. Tyrosine phosphorylation induced by C4 peptide constructs from HIV Gp120.
    Liu M; Zeng J; Robey FA
    Peptides; 1999; 20(2):185-91. PubMed ID: 10422873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
    Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA
    Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments.
    Chamow SM; Peers DH; Byrn RA; Mulkerrin MG; Harris RJ; Wang WC; Bjorkman PJ; Capon DJ; Ashkenazi A
    Biochemistry; 1990 Oct; 29(42):9885-91. PubMed ID: 2125484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV gets a taste of its own medicine.
    Cohen J
    Science; 1997 Sep; 277(5332):1606. PubMed ID: 9312856
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface expression of CD26 does not correlate with susceptibility to immunodeficiency viruses.
    West WH; Stott CJ
    AIDS; 1994 Sep; 8(9):1349-50. PubMed ID: 7802995
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of curdlan sulfate in the binding of HIV-1 gp120 to CD4 molecules and the production of gp120-mediated TNF-alpha.
    Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Sekigawa I; Hashimoto H; Hirose S; Murakami T; Yamamoto N; Mimura T; Kaneko Y
    Microbiol Immunol; 1997; 41(9):741-5. PubMed ID: 9343827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection: the cellular picture.
    Weber JN; Weiss RA
    Sci Am; 1988 Oct; 259(4):100-9. PubMed ID: 2854299
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins.
    Hansen JE; Nielsen CM; Nielsen C; Heegaard P; Mathiesen LR; Nielsen JO
    AIDS; 1989 Oct; 3(10):635-41. PubMed ID: 2574581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.